Law Offices of Thomas J. Lamb

  • Asbestos & Mesothelioma
  • Benzene Diseases
  • Camp Lejeune Cases
  • Drug Injury
  • Free Case Evaluation
  • About Us

Uloric-Related Acute Kidney Injury And Acute Renal Failure Pointed Out In Safety Study

January 22, 2020 By Law Offices of Thomas J. Lamb, P.A.

According to a recent medical journal article, acute renal failure (ARF), or kidney failure, is reported as an adverse drug reaction 5.7 times more frequently with Uloric (febuxostat) than with other urate-lowering therapy (ULT) gout drugs, and 3.3 times more often with allopurinol. This is some important new Uloric drug safety information from our … [Read more...]

Filed Under: Unsafe Drugs Tagged With: Acute Kidney Injury, acute renal failure, Kidney Failure, Renal Failure, Uloric

New Heartburn Drugs Study Shows 33% Increased Risk of Kidney Problems

November 8, 2017 By Law Offices of Thomas J. Lamb, P.A.

Previous Research on PPIs & Kidney Damage Several studies have been published in the past several years concerning the relationship between chronic kidney disease (CKD) and proton pump inhibitors (PPIs) such as Nexium, Prilosec, and Prevacid. The table below identifies the year, title, and results of three recent studies on PPIs and kidney … [Read more...]

Filed Under: Unsafe Drugs Tagged With: Acute Interstitial Nephritis, Acute Kidney Injury, ain, aki, chronic kidney disease, ckd, drug injury lawsuits, drug side effects, end stage renal disease, esrd, heartburn drugs, heartburn drugs side effects, Kidney Failure, Nexium, ppi drugs, Prevacid, Prilosec, proton pump inhibitors, Renal Failure, unsafe drugs

Could Invokana have been the cause of my lower-limb amputation?

September 15, 2017 By Law Offices of Thomas J. Lamb, P.A.

The FDA is investigating a connection between diabetes drugs belonging to the Sodium-Glucose Co-Transporter-2 (SGLT2) inhibitors class of drugs and the following side effects: Diabetic Ketoacidosis (DKA) Ketoacidosis Ketosis Acute Kidney Injury Kidney Failure / Renal Failure Kidney Damage Pyelonephritis (kidney infection) … [Read more...]

Filed Under: Unsafe Drugs Tagged With: Acute Kidney Injury, amputation risk factors, blood infection, diabetes drugs, diabetic ketoacidosis, DKA, drug injury lawsuits, Farxiga, Foot Amputation, Glyxambi, Invokamet, Invokana, Jardiance, Ketoacidosis, Ketosis, Kidney Damage, Kidney Failure, kidney infection, Leg Amputation, Pyelonephritis, Qtern, Renal Failure, sglt2 inhibitors, side effects of diabetes drugs, Sodium-Glucose Co-Transporter-2 inhibitors, Synjardy, Toes Amputation, Urinary Tract Infection, Urosepsis, UTI, Xigduo

Association Between Heartburn Drugs & Chronic Kidney Disease Questioned

September 7, 2017 By Law Offices of Thomas J. Lamb, P.A.

A recent article published in The Journal of Allergy and Clinical Immunology titled The “dangers” of chronic proton pump inhibitor use provides commentary on the relationship between use of proton pump inhibitors (PPIs)--such as Nexium, Prilosec, and Prevacid--and various side effects. The authors of this study acknowledge the growing number of … [Read more...]

Filed Under: Unsafe Drugs Tagged With: Acute Interstitial Nephritis, Acute Kidney Injury, ain, aki, chronic kidney disease, ckd, drug injury lawsuits, drug side effects, end stage renal disease, esrd, heartburn drugs, heartburn drugs side effects, Kidney Failure, Nexium, ppi drugs, Prevacid, Prilosec, proton pump inhibitors, Renal Failure, unsafe drugs

Can SGLT-2 Inhibitor Diabetes Drugs Increase Your Risk of Stroke?

June 21, 2017 By Law Offices of Thomas J. Lamb, P.A.

While we have frequently discussed DKA, kidney damage, and amputations as possible side effects of diabetes drugs in the SGLT-2 inhibitors class -- such as Farxiga, Invokana, Jardiance -- strokes and thromboembolic events are also considered potential harmful effects of these drugs. Based on FAERS reports received during the second quarter of … [Read more...]

Filed Under: Unsafe Drugs Tagged With: Acute Kidney Injury, Amputations, antidiabetic drugs, canagliflozin, canagliflozin/metformin HCl, causes of stroke, dapagliflozin, dapagliflozin/metformin HCl, Deep Vein Thrombosis, diabetes drugs, diabetic ketoacidosis, DKA, drug injury lawsuits, drug side effects, DVT, empagliflozin, empagliflozin/linagliptin, empagliflozin/metformin HCl, Farxiga, FDA, FDA FAERS reports, Glyxambi, Invokamet, Invokana, Jardiance, Kidney Damage, Kidney Failure, lower limb amputations, PE, Pulmonary Embolism, SGLT-2 inhibitors, Stroke, Synjardy, thromboembolic events, Xigduo, xigduo xr

Nexium / Prilosec / Prevacid: Valuing Profits Over Patients

March 21, 2017 By Law Offices of Thomas J. Lamb, P.A.

Nexium, Prilosec, and Prevacid are just a few of the popular heartburn and acid reflux drugs that have been linked with serious side effects relating to the kidneys.  These drugs are manufactured by AstraZeneca (Nexium / Prilosec) and Takeda (Prevacid). Though Nexium has been marketed as substantially different and more effective than Prilosec, … [Read more...]

Filed Under: Unsafe Drugs Tagged With: acid reflux drugs, Acute Interstitial Nephritis, Acute Kidney Injury, ain, aki, AstraZeneca, chronic kidney disease, ckd, end stage renal disease, esrd, heartburn drugs, Kidney Failure, Nexium, PPIs, Prevacid, Prilosec, proton pump inhibitors, Renal Failure, severe renal impairment, Takeda

Federal Court Invokana MDL In New Jersey With Judge Brian Martinotti

March 17, 2017 By Law Offices of Thomas J. Lamb, P.A.

Invokana (canagliflozin) was approved by the FDA in 2013.  Invokamet (canagliflozin and metformin) was approved by the FDA in 2014.  Both of these drugs were approved for use by patients with Type 2 diabetes. In December 2015 the FDA issued this Drug Safety Communication: “FDA revises labels of SGLT2 inhibitors for diabetes to include warnings … [Read more...]

Filed Under: Unsafe Drugs Tagged With: Acute Kidney Injury, diabetes drugs, Diabetic Ketoacidosis (DKA), Invokamet, Invokana, Ketoacidosis, Kidney Damage, type 2 diabetes drugs

Prevacid, Nexium, And Prilosec Linked To Risk Of Chronic Kidney Damage

February 27, 2017 By Law Offices of Thomas J. Lamb, P.A.

A recent medical study done by medical researchers in St. Louis, Missouri indicates that more than half of those patients who develop chronic kidney damage (CKD) while using proton pump inhibitors (PPIs) heartburn drugs and acid reflux medicines do not experience acute kidney problems before their CKD diagnosis. These researchers published their … [Read more...]

Filed Under: Unsafe Drugs Tagged With: Acute Kidney Injury, chronic kidney disease, Kidney Damage, Kidney Disease, Kidney Failure, kidney injury, Nexium, Prevacid, Prilosec, Renal Failure

December 2016: FDA Requires Safety Warnings Label Change For Jardiance

December 20, 2016 By Law Offices of Thomas J. Lamb, P.A.

After the December 2, 2016 decision by the FDA decision by U.S. regulators to expand the health benefits for the relatively new diabetes medicine Jardiance (empagliflozin) to include preventing fatal heart attacks and strokes in type 2 diabetes patients, we saw news reports about its expected effect on Jardiance sales in the U.S. From this … [Read more...]

Filed Under: Unsafe Drugs Tagged With: Acute Kidney Injury, drug injury, drug side effects, FDA, Jardiance, Ketoacidosis, Kidney Damage, Kidney Failure, mesothelioma

Farxiga / Jardiance / Invokana: Label Change Adds Ketoacidosis Warning

August 31, 2016 By Law Offices of Thomas J. Lamb, P.A.

In August 2016 the FDA sent letters to Janssen Pharmaceuticals and AstraZeneca Pharmaceuticals for label changes about fatal cases of ketoacidosis cases involving Invokana (canagliflozin), Invokamet (canagliflozin and metformin), Farxiga (dapagliflozin), and Xigduo XR (dapagliflozin and metformin extended-release). As for the other diabetes … [Read more...]

Filed Under: Unsafe Drugs Tagged With: Acute Kidney Injury, Cerebral Vascular Accident (CVA), Deep Vein Thrombosis (DVT), Farxiga, Glyxambi, Heart Attacks, Invokamet, Invokana, Ischemic Stroke, Jardiance, Ketoacidosis, Kidney Damage, Kidney Failure, Myocardial Infarctions (MI), Pulmonary Embolism (PE), Pyelonephritis, Renal Failure, Synjardy, Urinary Tract Infection (UTI), Urosepsis, Xigduo

  • 1
  • 2
  • Next Page »

Find What You Want Here

Get Free Case Evaluation

We encourage you to submit an online Case Evaluation Form – it is confidential and there is no obligation.

Or call our toll-free number, 800-426-9535, to speak directly to attorney Tom Lamb about your possible case.

Feel Free To Contact Us

Quick Contact Form
 
Send an Email to Tom Lamb

(800) 426-9535

Main Navigation Menu

  • About Our Firm
  • Asbestos-Mesothelioma Cases
  • Benzene Disease Claims
  • Camp Lejeune Cases
  • GenX Water Cancer Cases
  • Drug Injury Lawsuits
  • Breast Implant Cancer Cases
  • Philips Breathing Devices Cases
  • Case Evaluation Menu
  • Quick Contact Form
  • Frequently Asked Questions
  • Medical Records Charges
  • Collection of Articles
  • Sitemap

Lamb Law Office Newsletter

Lamb Law Office Newsletter provides periodic updates about some of the cases that we are working on for clients, as well as an information resource you might find helpful.

Subscribe using Form below.

Subscription Form

* indicates required

Our Other Websites

Drug Injury Law
Drug Injury Watch
Drug Safety Developments
Asbestos & Mesothelioma

Contact Information

Law Offices of Thomas J. Lamb, P.A.
1908 Eastwood Road, Suite 225
Wilmington, North Carolina 28403
910-256-2971 | 800-426-9535
TJL@LambLawOffice.com

  • Home
  • Frequently Asked Questions
  • Disclaimer and Copyright Notices

Copyright © 2023 · Law Offices of Thomas J. Lamb, P.A.